Holen Sie sich die Stockscreener-App
283.85
1.07%
-3.07
Handel nachbörslich:
281.85
-2.00
-0.70%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$286.92
Offen:
$284.085
24-Stunden-Volumen:
2.58M
Relative Volume:
1.13
Marktkapitalisierung:
$152.81B
Einnahmen:
$34.76B
Nettoeinkommen (Verlust:
$6.62B
KGV:
23.21
EPS:
12.23
Netto-Cashflow:
$10.61B
1W Leistung:
-1.43%
1M Leistung:
-4.39%
6M Leistung:
-8.67%
1J Leistung:
-14.12%
1-Tages-Spanne:
$280.38
$286.93
1-Wochen-Bereich:
$280.38
$288.74
52-Wochen-Spanne:
$253.30
$339.17
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Vergleichen Sie AMGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
283.85 | 154.47B | 34.76B | 6.62B | 10.61B | 12.23 |
|
LLY
Lilly Eli Co
|
737.83 | 659.07B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
178.00 | 428.83B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
211.86 | 374.37B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
128.23 | 245.16B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
84.18 | 213.51B | 63.43B | 16.42B | 14.72B | 6.49 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Baird Financial Group Inc. Sells 26,571 Shares of Amgen Inc. $AMGN - MarketBeat
Evergreen Capital Management LLC Boosts Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Smead Capital Management Inc. - MarketBeat
The Manufacturers Life Insurance Company Purchases 600,096 Shares of Amgen Inc. $AMGN - MarketBeat
Zacks Research Predicts Amgen's Q3 Earnings (NASDAQ:AMGN) - MarketBeat
Decoding the Genetics of Obesity - Amgen
Amgen, Zai Lab say stomach cancer drug's survival benefit dropped in Phase 3 - Endpoints News
Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential - MSN
Amgen Stock (AMGN) Slips on $600M Research Hub News - TipRanks
Amgen (AMGN) Unveils US$600 Million Innovation Hub Expanding R&D Efforts in California - simplywall.st
Amgen’s Strategic Focus and Portfolio Strength Justify Buy Rating Despite Bemarituzumab Challenges - TipRanks
Amgen dips after trial update for Zai Lab partnered gastric cancer therapy - Seeking Alpha
Amgen Inc. stock trend forecast2025 Macro Impact & Daily Volume Surge Signals - Newser
First Manhattan CO. LLC. Has $30.64 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen to Invest $600 Million in New Science and Innovation Center at US Headquarters - geneonline.com
GW Henssler & Associates Ltd. Lowers Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by First Financial Bankshares Inc - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Ameriflex Group Inc. - MarketBeat
Amgen Inc. $AMGN Shares Sold by Lansforsakringar Fondforvaltning AB publ - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Ieq Capital LLC - MarketBeat
Amgen Inc. $AMGN Stock Holdings Increased by Landscape Capital Management L.L.C. - MarketBeat
Trexquant Investment LP Sells 36,293 Shares of Amgen Inc. $AMGN - MarketBeat
Canada Pension Plan Investment Board Sells 145,702 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Raised by Calton & Associates Inc. - MarketBeat
Using data models to predict Amgen Inc. stock movementJuly 2025 Trade Ideas & Safe Capital Growth Plans - Newser
Will Amgen Inc. benefit from macro trends2025 Big Picture & Free High Return Stock Watch Alerts - Newser
Should you hold or exit Amgen Inc. nowJuly 2025 Update & Short-Term Swing Trade Alerts - Newser
Amgen invests big in new science and innovation center - The Pharma Letter
Applying chart zones and confluence areas to Amgen Inc.July 2025 Final Week & Capital Protection Trading Alerts - Newser
Can momentum traders help lift Amgen Inc.July 2025 Price Swings & Daily Chart Pattern Signal Reports - Newser
CreativeOne Wealth LLC Increases Position in Amgen Inc. $AMGN - MarketBeat
Jump Financial LLC Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Tema Etfs LLC Trims Position in Amgen Inc. $AMGN - MarketBeat
Amgen to invest $600m in new US science and innovation hub - Pharmaceutical Technology
Will Amgen Inc. see short term momentumSell Signal & High Return Stock Watch Alerts - Newser
FORA Capital LLC Has $227,000 Stock Position in Amgen Inc. $AMGN - MarketBeat
Navigating Sector Divergence: Nio, Signet, and Amgen in a Shifting Market - AInvest
Amgen Inc. $AMGN Shares Purchased by OMERS ADMINISTRATION Corp - MarketBeat
Why Amgen Inc. is moving todayProfit Target & AI Forecasted Stock Moves - Newser
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):